Geninax(R) Tablets 200 mg was administered under the approved regimen (2 tablets of Geninax(R), once daily). The administration period was not limited.
Sponsors
Toyama Chemical Co., Ltd.
Conditions
Atypical pneumoniaBacterial pneumonia
Phase 4
Specific post-marketing surveillance of Geninax(R) Tablets 200 mg Efficacy and safety against bacterial pneumonia
Active, not recruitingJPRN-UMIN000012124
Start: 2009-10-09Target: 500Updated: 2026-06-29
Specific post-marketing surveillance of Geninax(R) Tablets 200 mg Efficacy and safety against atypical pneumonia
Active, not recruitingJPRN-UMIN000012125
Start: 2009-11-26Target: 100Updated: 2026-06-29